CPSF3-dependent pre-mRNA processing as a druggable node in AML and Ewing’s sarcoma
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
The post-genomic era has seen many advances inBaryza and G. Rice for helpful our understanding of cancer pathways, yet resistance and tumor heterogeneity necessitate multiple approaches to target even monogenic tumors. Here, we combine phenotypic screening with chemical genetics to identify pre-messenger RNA endonuclease cleavage and polyadenylation specificity factor 3 (CPSF3) as the target of JTE-607, a small molecule with previously unknown target. We show that CPSF3 represents a synthetic lethal node in a subset of acute myeloid leukemia (AML) and Ewing’s sarcoma cancer cell lines. Inhibition of CPSF3 by JTE-607 alters expression of known downstream effectors in AML and Ewing’s sarcoma lines, upregulates apoptosis and causes tumor-selective stasis in mouse xenografts. Mechanistically, it prevents the release of newly synthesized pre-mRNAs, resulting in read-through transcription and the formation of DNA-RNA hybrid R-loop structures. This study implicates pre-mRNA processing, and specifically CPSF3, as a druggable target providing an avenue to therapeutic intervention in cancer. The RNA endonuclease CPSF3 was identified as the cellular efficacy target of the small molecule JTE-607, revealing pre-mRNA processing as a vulnerability in cancers such as Ewing’s sarcoma that are characterized by aberrant transcription.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Systematic identification of genomic markers of drug sensitivity in cancer cells
Garnett, M. J., Edelman, E. J., Heidorn, S. J., Greenman, C. D., Dastur, A., Lau, K. W., Greninger, P., Thompson, I. R., Luo, X., Soares, J., et al. (2012) · Nature · doi:10.1038/nature11005 · Cited by 2,456
How were new medicines discovered?
Swinney, D. C., & Anthony, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3480 · Cited by 1,812
Opportunities and challenges in phenotypic drug discovery: an industry perspective
Moffat, J. G., Vincent, F., Lee, J. A., Eder, J., & Prunotto, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.111 · Cited by 939
Smart, O. S., Womack, T. O., Flensburg, C., Keller, P., Paciorek, W., Sharff, A., Vonrhein, C., & Bricogne, G. (2012) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444911056058 · Cited by 612
SMN2 splice modulators enhance U1–pre-mRNA association and rescue SMA mice
Palacino, J., Swalley, S. E., Song, C., Cheung, A. K., Shu, L., Zhang, X., Van Hoosear, M., Shin, Y., Chin, D. N., Keller, C. G., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1837 · Cited by 432
Self-citationGeneMANIA Prediction Server 2013 Update
Zuberi, K., Franz, M., Rodriguez, H., Montojo, J., Lopes, C. T., Bader, G. D., & Morris, Q. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt533 · Cited by 396
CDK12 regulates DNA repair genes by suppressing intronic polyadenylation
Dubbury, S. J., Boutz, P. L., & Sharp, P. A. (2018) · Nature · doi:10.1038/s41586-018-0758-y · Cited by 318
EWS/FLI confers tumor cell synthetic lethality to CDK12 inhibition in Ewing sarcoma
Iniguez, A. B., Stolte, B., Wang, E. J., Conway, A. S., Alexe, G., Dharia, N. V., Kwiatkowski, N., Zhang, T., Abraham, B. J., Mora, J., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2017.12.009 · Cited by 173
Cited by
Context-specific regulation and function of mRNA alternative polyadenylation
Mitschka, S., & Mayr, C. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00507-5 · Cited by 336
Surface antigen-guided CRISPR screens identify regulators of myeloid leukemia differentiation
Wang, E., Zhou, H., Nadorp, B., Cayanan, G., Chen, X., Yeaton, A. H., Nomikou, S., Witkowski, M. T., Narang, S., Kloetgen, A., et al. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2020.12.005 · Cited by 66
RBBP6 activates the pre-mRNA 3′ end processing machinery in humans
(2022) · doi:10.1101/gad.349223.121 · Cited by 61
Li, X., Li, S., Li, B., Li, Y., Aman, S., Xia, K., Yang, Y., Ahmad, B., & Wu, H. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00158-3 · Cited by 20
Molecular details of the CPSF73-CPSF100 C-terminal heterodimer and interaction with Symplekin
Thore, S., Raoelijaona, F., Talenton, V., Fribourg, S., & Mackereth, C. D. (2023) · Open Biology · doi:10.1098/rsob.230221 · Cited by 6
Metadata
- Authors
- Ross, N. T., Lohmann, F., Carbonneau, S., Fazal, A., Weihofen, W. A., Gleim, S., Salcius, M., Sigoillot, F., Henault, M., Carl, S. H., Rodríguez-Molina, J. B., Miller, H. R., Brittain, S. M., Murphy, J., Zambrowski, M., Boynton, G., Wang, Y., Chen, A., Molind, G. J., Wilbertz, J. H., Artus-Revel, C. G., Jia, M., Akinjiyan, F. A., Turner, J., Knehr, J., Carbone, W., Schuierer, S., Reece-Hoyes, J. S., Xie, K., Saran, C., Williams, E. T., Roma, G., Spencer, M., Jenkins, J., George, E. L., Thomas, J. R., Michaud, G., Schirle, M., Tallarico, J., Passmore, L. A., Chao, J. A., & Beckwith, R. E. J.
- Venue
- Nature Chemical Biology
- Published
- 2019-12-09
- Volume
- 16
- Issue
- 1
- Pages
- 50-59
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- OpenAlex
- W2993193059
- Cited by
- 91
- References
- 8
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CPSF3-dependent pre-mRNA processing as a druggable node in AML and Ewing’s sarcoma. https://app.cochat.ai/papers/10.1038/s41589-019-0424-1
- The paper
- Ross, N. T., Lohmann, F., Carbonneau, S., Fazal, A., Weihofen, W. A., Gleim, S., Salcius, M., Sigoillot, F., Henault, M., Carl, S. H., Rodríguez-Molina, J. B., Miller, H. R., Brittain, S. M., Murphy, J., Zambrowski, M., Boynton, G., Wang, Y., Chen, A., Molind, G. J., . . . Beckwith, R. E. J. (2020). CPSF3-dependent pre-mRNA processing as a druggable node in AML and Ewing’s sarcoma. Nature Chemical Biology. https://doi.org/10.1038/s41589-019-0424-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.